| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $22.9M | -19.6% | -13.0% |
| SG&A Expense | $5.1M | +28.5% | -26.1% |
| Operating Income | -$28.0M | +13.7% | +15.7% |
| Interest Expense | $12K | — | +1100.0% |
| Pre-tax Income | -$26.9M | +14.0% | +11.9% |
| Income Tax | $0 | — | — |
| Net Income | -$26.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.1M | -16.2% | -72.4% |
| Current Assets | $106.5M | -16.6% | -48.4% |
| Total Assets | $140.5M | -13.8% | -42.9% |
| Current Liabilities | $18.9M | +10.9% | -2.3% |
| Total Liabilities | $31.3M | +5.9% | -9.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$74.3M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | $46.9M | — | — |
| Financing Cash Flow | $13K | — | — |
| Free Cash Flow | -$76.1M | — | — |
| +11.9% |
| EPS (Basic) | -$0.29 | +14.7% | +14.7% |
| EPS (Diluted) | -$0.29 | +14.7% | +14.7% |
| $109.1M |
| -18.2% |
| -48.4% |